Ranbaxy and Daiichi Sankyo successfully completes landmark deal

Ranbaxy and Daiichi Sankyo successfully completes landmark deal Ranbaxy Laboratories and Daiichi Sankyo Company has announced the successful closure of their transformational deal with the execution of the final transfer of the remaining equity shares of the Singh family, in Ranbaxy. Pursuant to this, Daiichi Sankyo has now acquired 63.92% of the equity share capital of Ranbaxy comprising 268,711,323 shares. The company made this announcement during the trading hours today, 07 November 2008